![Koen Dewaele](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Koen Dewaele
Sociétés | Poste | Début | Fin |
---|---|---|---|
ADx NeuroSciences NV
![]() ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Directeur/Membre du Conseil | 01/01/2011 | - |
Directeur Général | 01/01/2011 | - | |
Fondateur | 01/01/2011 | - |
Historique de carrière de Koen Dewaele
Statistiques
Internationale
Belgique | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
ADx NeuroSciences NV
![]() ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Health Technology |
- Bourse
- Insiders
- Koen Dewaele
- Expérience